Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers

Human rhinovirus (HRV) infections are usually self-limited but may be associated with serious consequences, particularly in those with asthma and chronic respiratory disease. Effective antiviral agents are needed for preventing and treating HRV illnesses. Ruprintrivir (Agouron Pharmaceuticals, Inc.,...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Hayden, Frederick G., Turner, Ronald B., Gwaltney, Jack M., Chi-Burris, Kathy, Gersten, Merril, Hsyu, Poe, Patick, Amy K., Smith, George J., Zalman, Leora S.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2003
Sujets:	Antiviral Agents
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296196/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14638501/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.12.3907-3916.2003
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!